GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) » Definitions » 5-Year Yield-on-Cost %

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) 5-Year Yield-on-Cost % : 1.88 (As of May. 28, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Shenzhenlubris Pharmaceuticals Co 5-Year Yield-on-Cost %?

Shenzhenlubris Pharmaceuticals Co's yield on cost for the quarter that ended in Mar. 2024 was 1.88.


The historical rank and industry rank for Shenzhenlubris Pharmaceuticals Co's 5-Year Yield-on-Cost % or its related term are showing as below:

SZSE:002294' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.75   Med: 1.69   Max: 4.6
Current: 1.88


During the past 13 years, Shenzhenlubris Pharmaceuticals Co's highest Yield on Cost was 4.60. The lowest was 0.75. And the median was 1.69.


SZSE:002294's 5-Year Yield-on-Cost % is ranked worse than
58.25% of 309 companies
in the Medical Devices & Instruments industry
Industry Median: 2.18 vs SZSE:002294: 1.88

Competitive Comparison of Shenzhenlubris Pharmaceuticals Co's 5-Year Yield-on-Cost %

For the Medical Instruments & Supplies subindustry, Shenzhenlubris Pharmaceuticals Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhenlubris Pharmaceuticals Co's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhenlubris Pharmaceuticals Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Shenzhenlubris Pharmaceuticals Co's 5-Year Yield-on-Cost % falls into.



Shenzhenlubris Pharmaceuticals Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Shenzhenlubris Pharmaceuticals Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Shenzhenlubris Pharmaceuticals Co  (SZSE:002294) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Shenzhenlubris Pharmaceuticals Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Shenzhenlubris Pharmaceuticals Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Business Description

Traded in Other Exchanges
N/A
Address
1901 Chuangzhan Center, 6007 Shennan Road, Futian District, Shenzhen, CHN
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, innovative biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other global countries and regions.
Executives
Yan Jie Directors, executives
Yang Jian Feng Secretary, Director
Zhao Song Ping Executives
Liu Jun Executives
Li Ai Zhen Supervisors
Chen Ping Executives
Ye Cheng Hai Director
Lu Feng Executives, directors
Chen Qiong Xing Supervisors
Li Ying Hui Supervisors
Pan Ling Man Independent director
Zhang Zhong Xing Executives

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Headlines

No Headlines